How Can We Manage the Increasing Complexity of Clinical Trial Protocols?: Interview with Ken Getz of Tufts Center for the Study of Drug Development
Ken Getz joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the growing complexity in clinical trial protocols. The Director…
Molly Bryant
Increasing Access to People of African Descent in Pharma: Interview with Peju Oshisanya
Peju Oshisanya joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
How Can We Manage the Increasing Complexity of Clinical Trial Protocols?: Interview with Ken Getz of Tufts Center for the Study of Drug Development
Ken Getz joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
An Honest Look at How Demanding Oncology Trials Have Become: Interview with Rebecca Setta of Oncosec
Rebecca Setta joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
What Do You Do When You Don’t Have Enough Clinical Trial Locations: Interview with Krystyna Kowalczyk of Oncobay
Krystyna Kowalczyk joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
When Seeking Diversity during Site Selection, Look Beyond Historical Data to Discover Untapped Patient Populations
We recently spoke with Liz Beatty, Chief Strategy Officer at Inato about how the company…
Molly Bryant
Helping Sites and Teams Make the Shift to Decentralized Trials: Interview with Paul Evans of Velocity Clinical Research
Paul Evans of Velocity Clinical Research talks with Kelly Ritch, EVP of Product and Clinical…
Molly Bryant
The Evolving Role of Sites in Virtual & Decentralized Trials: Interview with Mary Costello of Medable
Mary Costello talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, about how…
Molly Bryant
Demystifying Decentralized Clinical Trials: Interview with R’Kes Starling of Reveles Clinical
R'Kes Starling joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
To Succeed with Virtual or Hybrid Clinical Trials, Listen to Patients and Sites
We recently spoke about virtual and hybrid clinical trials with Amy O’Sullivan, Director of North…
Molly Bryant
Conversations in Clinical Trial Readiness: Kunal Sampat of Ceribell
Kunal Sampat joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
Industry insights you won’t delete. Delivered to your inbox monthly.
Interview: Start-Up Phase is a Prime Target for Virtual Activities in Clinical Trials, So Let’s Adapt
We recently spoke with Mike McLaughlin, Associate Director, Clinical Operations at Dermavant Sciences Inc., a…
Molly Bryant
Interview: Adopting Consumer Tech in Clinical Trials Will Pave the Way for Hybrid and Virtual Trials
We recently spoke with Kemi Olugemo, M.D., Executive Medical Director, Neurology Clinical Development at Akcea…
Molly Bryant
Interview: COVID-19 Has Forced Clinical Research to Innovate, but We Must Do More
We recently spoke with Mark Shapiro, Partner at Pharma Initiatives, a specialty consultancy focused on…
Kelly Ritch
Interview: The People-First Approach to Success in Clinical Trials
We recently spoke with Carl Cook, Vice President of Clinical Operations at Black Diamond Therapeutics,…
Kelly Ritch
Interview: One ClinOps Leader Tells His Story on Site Preparedness, and Offers the Industry Some Advice
We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based…
Kelly Ritch
Interview: Managing Studies In A Rapidly Changing Treatment Environment
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech…
Kelly Ritch
Experience ArcheMedX For Yourself
See how the ArcheMedX Platform can transform your organization’s learning and insights